Travere Therapeutics (TVTX) Q1 2025 Earnings

20FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.76
-1.36
-0.96
-0.56

Details

Expected EPS
-0.562024
Actual EPS
-0.73
Surprise EPS
-0.17
Surprise Percent
+29.89%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.73 per share for Q1 2025.

0 Comments

Share your thoughts